跳至主要内容
临床试验/JPRN-UMIN000020707
JPRN-UMIN000020707已完成未知

FDG-PET/MRI imaging for the evaluation of early response to nivolumab in patients with previously treated non-small cell lung cancer - FDG-PET/MRI imaging for the evaluation of early response to nivolumab in patients with previously treated non-small cell lung cancer

Third department of internal medicine, Universtiy of Fukui0 个研究点目标入组 25 人开始时间: 2016年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

Patients with non-progressive disease (non-PD) had significantly decreased TLG, increased ADCmean (that is, negative dADCmean), and lower dTLG+dADCmean than patients with PD. Among the parameters tested, receiver operating characteristic curve analysis revealed that a cut-off value of 16.5 for dTLG+dADCmean had the highest accuracy (92%) for distinguishing between non-PD and PD patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Fasting serum glucose levels above 150 mg/dl 2) Pregnant woman 3) Patients with metalic device in their body 4) Patients with claustrophobia 5) Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X-ray. 6) Patients with collagen vascular disease or autoimmune diseases 7) Other cases attending physician it is determined unsuitable for registration of the study

研究者

发起方
Third department of internal medicine, Universtiy of Fukui

相似试验